The Effectiveness on Prevention of Rehospitalization with Long-Term Psychosocial Interventions for Patients with Major Psychiatric Disorders
10.16946/kjsr.2019.22.2.66
- Author:
Jae Hoon JEONG
1
;
Min Jeong KANG
;
Min Young KWON
;
Sang Min LEE
;
Kyu Young LEE
Author Information
1. Department of Psychiatry, Eulji University School of Medicine, Daegeon, Korea. lky@eulji.ac.kr
- Publication Type:Original Article
- Keywords:
Major psychiatric disorder;
Mental health center;
Psychosocial intervention;
Rehospitalization
- MeSH:
Case Management;
Hospitalization;
Humans;
Mental Health;
Mood Disorders;
Schizophrenia
- From:Korean Journal of Schizophrenia Research
2019;22(2):66-73
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: This study aimed to elucidate the effectiveness of long-term psychosocial intervention in reducing the disabling period of patients with major psychiatric disorders by their rehospitalization rate. METHODS: Of the 210 patients with major psychiatric disorders received psychosocial interventions in a Mental Health and Welfare Center, 192 patients (147 with schizophrenia spectrum disorders, 45 with mood disorders) who received interventions more than 6 months were selected. Review of case management records was conducted to obtain information. RESULTS: The number and length of hospitalization and the hospital days per year significantly decreased after psychosocial intervention. Additional analysis of 102 patients followed up for more than 5 years suggested that the effectiveness of the intervention persisted for a sufficient period. However, no significant difference was observed in the number of rehospitalization in 45 patients with mood disorders, though the length of hospitalization significantly decreased. In addition, the hospital days per year of 21 patients with mood disorder followed up for more than 5 years also showed no significant decrease. CONCLUSION: Long-term psychosocial intervention had a significant effect on reducing the number and length of hospitalization for patients with major psychiatric disorder and the effectiveness maintained for more than 5 years.
